Neurology and Therapy (Jan 2024)

Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review

  • Sharon Stoll,
  • Kathleen Costello,
  • Scott D. Newsome,
  • Hollie Schmidt,
  • Amy B. Sullivan,
  • Barry Hendin

DOI
https://doi.org/10.1007/s40120-023-00573-7
Journal volume & issue
Vol. 13, no. 1
pp. 21 – 37

Abstract

Read online

Abstract Shared decision-making (SDM) between the patient and their healthcare provider (HCP) in developing treatment plans is increasingly recognized as central to improving treatment adherence and, ultimately, patient outcomes. In multiple sclerosis (MS), SDM is particularly crucial for optimizing treatment in a landscape that has grown more complex with the availability of newer, high-efficacy MS therapies. However, little direct evidence on the effectiveness of SDM is available to guide practice. Multiple factors, including patient age, ethnic background, perceptions, invisible MS symptoms, and psychological comorbidities can influence a patient’s willingness and ability to participate in SDM. HCPs need to appreciate these factors and ask the right questions to break down obstacles to SDM. The HCP has a responsibility to help patients feel adequately informed and comfortable in having an active role in their care. This review identifies potential barriers to SDM and provides a strategy for HCPs to overcome these obstacles through patient (and caregiver) discussions to ensure optimal patient satisfaction with treatment and thus the best possible outcomes for their patients.

Keywords